Pamica NV

Pamica NV is a Belgian private investment firm specializing in technology and life sciences sectors. The firm focuses on investments in internet and software companies, aiming to support their growth and development. Pamica NV is led by Michel Akkermans, a serial entrepreneur and private investor with extensive experience in the technology sector. Under his leadership, the firm has been actively involved in various investments and has a track record of supporting companies through different stages of their development. Pamica NV's investment approach is characterized by a hands-on strategy, providing not only capital but also strategic guidance to its portfolio companies. The firm has been involved in several notable investments, including miDiagnostics, which secured €30 million in a Series D funding round led by Thermo Fisher Scientific in December 2024. Additionally, Pamica NV has been active in the cybersecurity sector, with investments in companies like Ceeyu, which aims to expand its European presence. The firm's portfolio also includes Contract.fit, a Brussels-based AI company that was acquired by a British firm in September 2024. Pamica NV's commitment to supporting innovative companies in the technology and life sciences sectors underscores its role as a significant player in the Belgian investment landscape. The firm's strategic focus and active involvement in its portfolio companies reflect its dedication to fostering growth and innovation in these critical industries. Pamica NV's investment philosophy emphasizes long-term partnerships and value creation. The firm seeks to identify companies with strong growth potential and works closely with management teams to implement strategies that drive sustainable success. This approach has enabled Pamica NV to build a diverse portfolio of companies that are leaders in their respective fields. The firm's expertise in the technology and life sciences sectors allows it to provide valuable insights and support to its portfolio companies, facilitating their expansion and market penetration. Pamica NV's proactive investment style and deep industry knowledge have contributed to its reputation as a trusted partner for companies seeking to scale and achieve their strategic objectives. The firm's involvement in various sectors, including software, internet, and cybersecurity, demonstrates its adaptability and commitment to investing in areas with high growth prospects. Through its strategic investments and active management, Pamica NV continues to play a pivotal role in the development of innovative companies in Belgium and beyond. The firm's focus on technology and life sciences aligns with global trends towards digitalization and healthcare advancements, positioning it well to capitalize on emerging opportunities. Pamica NV's dedication to fostering innovation and supporting entrepreneurial ventures underscores its significance in the investment community. The firm's ongoing efforts to expand its portfolio and engage in meaningful partnerships reflect its commitment to driving economic growth and technological progress.

Strong growth potential, Alignment with technological innovation, Demonstrated market demand, Scalable business model, Experienced management team, Clear exit strategy, Companies in technology and life sciences sectors with strong growth potential, Businesses seeking strategic guidance and capital investment, Enterprises aiming for expansion and market penetration